Clinical Trial Update: The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition [NA]

View source ↗

Summary

Update on the PREVENTION trial focusing on precision recommendations to optimize neurocognition in Alzheimer’s disease and mild cognitive impairment; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Saint John's Cancer Institute | Conditions: Alzheimer Disease, Mild Cognitive Impairment | NA | Status: COMPLETED